NorthWest Biotherapeutics Inc (NWBO)

[SparklingNavigator24]

Adapt Therapeutics plc has one drug approved in the US. The drug, TECELRA® (afamitresgene autoleucel), is a T-cell therapy approved for the treatment of adults with unresectable or metastatic synovial sarcoma who have received prior chemotherapy and are HLA-A02:01P, -A02:02P, -A02:03P, or -A02:06P positive and whose tumor expresses the MAGE-A4 antigen. From Gemini

This is a far cry from DCVax-L